• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Journal of Medical Histology
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 8 (2024)
Volume Volume 7 (2023)
Volume Volume 6 (2022)
Issue Issue 2
Issue Issue 1
Volume Volume 5 (2021)
Volume Volume 4 (2020)
Volume Volume 3 (2019)
Volume Volume 2 (2018)
Volume Volume 1 (2017)
Kattaia, A., Abd EL-Baset, S., Abdul-Maksoud, R., Mohamed, E. (2022). The therapeutic potential of exosomes derived from mesenchymal stem cells in experimentally induced hypertensive encephalopathy. Journal of Medical Histology, 6(1), 16-33. doi: 10.21608/jmh.2022.145535.1100
Asmaa Kattaia; Samia Abd EL-Baset; Rehab Abdul-Maksoud; Eman Mohamed. "The therapeutic potential of exosomes derived from mesenchymal stem cells in experimentally induced hypertensive encephalopathy". Journal of Medical Histology, 6, 1, 2022, 16-33. doi: 10.21608/jmh.2022.145535.1100
Kattaia, A., Abd EL-Baset, S., Abdul-Maksoud, R., Mohamed, E. (2022). 'The therapeutic potential of exosomes derived from mesenchymal stem cells in experimentally induced hypertensive encephalopathy', Journal of Medical Histology, 6(1), pp. 16-33. doi: 10.21608/jmh.2022.145535.1100
Kattaia, A., Abd EL-Baset, S., Abdul-Maksoud, R., Mohamed, E. The therapeutic potential of exosomes derived from mesenchymal stem cells in experimentally induced hypertensive encephalopathy. Journal of Medical Histology, 2022; 6(1): 16-33. doi: 10.21608/jmh.2022.145535.1100

The therapeutic potential of exosomes derived from mesenchymal stem cells in experimentally induced hypertensive encephalopathy

Article 2, Volume 6, Issue 1, June 2022, Page 16-33  XML PDF (6.46 MB)
Document Type: Original Article
DOI: 10.21608/jmh.2022.145535.1100
View on SCiNiTO View on SCiNiTO
Authors
Asmaa Kattaia1; Samia Abd EL-Baset email orcid 1; Rehab Abdul-Maksoud2; Eman Mohamed2
1Department of Medical Histology and Cell Biology ,Faculty of Medicine, Zagazig University, Zagazig, Egypt
2Department of Medical Biochemistry, Faculty of Medicine, Zagazig University, Zagazig, Egypt
Abstract
Background and objectives: Cerebrovascular complications of hypertension are highly dangerous. In recent studies, exosomes
have been widely used in several disease research areas, including hypertension research. Mesenchymal stem cells (MSCs)
release high levels of exosomes. Therefore, we investigated the role of MSC-derived exosomes in alleviating hypertensioninduced
changes in the cerebral cortex of a rat model.
Methods: A total of 30 rats were assigned to control, hypertensive, and exosome-treated groups which received 100 μg MSCderived
exosomes total protein via tail vein. Tissue samples were examined for gene expression using real-time quantitative
polymerase chain reaction (RT-qPCR) and light and electron microscopy.
Results and conclusion: BExosome treatment recovered blood vessels, neural cells and blood-brain barrier (BBB) alterations
as verified by upregulated endothelial nitric oxide synthase (eNOS) and AMP-activated protein kinase (AMPK) mRNA,
downregulated α-smooth muscle actin (α-SMA) mRNA, and enhanced angiogenic factors, miRNA-222 and Tie2 protein.
Exosomes exerted anti-apoptotic effects by increasing Bcl-xl expression and decreasing caspase 3 protein levels in immune
histochemical sections. The anti-inflammatory potential of exosomes was indicated by reduced IL-1β mRNA and microglia
activation factor Iba1 protein levels. Neuronal protection was supported by upregulated miRNA-133b and calbindin D28K
(CB) protein levels. Moreover, the astrocyte vascular feet protein aquaporin (AQP4) was downregulated. MSC-derived
exosomes may be considered a novel strategy for treating cerebral hypertension complications
Keywords
Cerebral cortex; Exosomes; Hypertension; Rat
Statistics
Article View: 187
PDF Download: 537
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.